Treatment Guidelines from The Medical Letter
FROM
ISSUE
103
March 1, 2011
View Complete Issue         Table of Contents 2019 
Issue 103
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Drugs for Lipids
March 1, 2011 (Issue: 103)
Drugs that lower low-density lipoprotein cholesterol (LDL-C) concentrations can prevent formation, slow progression and cause regression of atherosclerotic lesions. Lipid-regulating drugs must be taken indefinitely; when they are stopped, plasma...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 103
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.